Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Second Primary Malignancies in Mantle Cell Lymphoma: A U.S. Population-based Study

BINAY KUMAR SHAH and AMIT KHANAL
Anticancer Research June 2015, 35 (6) 3437-3440;
BINAY KUMAR SHAH
1Cancer Center and Blood Institute, St. Joseph Regional Medical Center, Lewiston, ID, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: binay.shah@gmail.com
AMIT KHANAL
2University of Illinois at Chicago, Chicago, IL, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 35 no. 6 3437-3440

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received February 24, 2015
  • Revision received March 5, 2015
  • Accepted March 9, 2015
  • Published online May 29, 2015.

Copyright & Usage 
Copyright© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. BINAY KUMAR SHAH1⇑ and
  2. AMIT KHANAL2
  1. 1Cancer Center and Blood Institute, St. Joseph Regional Medical Center, Lewiston, ID, U.S.A.
  2. 2University of Illinois at Chicago, Chicago, IL, U.S.A.
  1. Correspondence to: Dr. Binay Kumar Shah, Cancer Center and Blood Institute, St. Joseph Regional Medical Center, 1250 Idaho Street, Lewiston, 83501 ID, U.S.A. Tel: +1 2087437427, Fax: +1 2087437421, e-mail: binay.shah{at}gmail.com
View Full Text

Cited By...

  • 8 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Anticancer Research: 35 (6)
Anticancer Research
Vol. 35, Issue 6
June 2015
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Second Primary Malignancies in Mantle Cell Lymphoma: A U.S. Population-based Study
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Second Primary Malignancies in Mantle Cell Lymphoma: A U.S. Population-based Study
BINAY KUMAR SHAH, AMIT KHANAL
Anticancer Research Jun 2015, 35 (6) 3437-3440;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Second Primary Malignancies in Mantle Cell Lymphoma: A U.S. Population-based Study
BINAY KUMAR SHAH, AMIT KHANAL
Anticancer Research Jun 2015, 35 (6) 3437-3440;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: extended 3.5-year follow up from a pooled analysis
  • Google Scholar

More in this TOC Section

  • Efficacy and Safety of Lenvatinib After Progression on First-line Atezolizumab Plus Bevacizumab Treatment in Advanced Hepatocellular Carcinoma Patients
  • Efficacy and Safety of Platinum-based Chemotherapy With Bevacizumab Followed by Bevacizumab Maintenance for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer During PARP Inhibitor Therapy: A Multicenter Retrospective Study
  • Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for Head and Neck Cancer
Show more Clinical Studies

Similar Articles

Keywords

  • mantle cell lymphoma
  • SEER
  • second primary malignancies
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire